Project Grant R21AI185887
Award Date
7/19/24
Completion Date
5/31/26
Dollars Obligated
$517K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Irvine, CA 92618, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $192,260 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Virginia (UVA). The 5-year grant, active from March 1, 2025 to February 28, 2030, supports research to characterize the systemic and mucosal immune response to adenovirus 40/41 infection in Bangladeshi children. The grant has two key objectives: 1) Describe the antibody repertoire to adenovirus 40/41 in...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $318,085 to support research on the role of antibodies in controlling virus infections through Fc-dependent mechanisms such as antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytolysis (CDC). The research aims to elucidate the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $303,076 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Washington. The grant, awarded on November 5, 2024, supports research to understand how viruses evade and co-opt the body's innate immune defenses, specifically focusing on how enteric viruses develop resistance to antimicrobial peptides called defensins. The research aims to elucidate the molecular,...
This Project Grant award of $233,528 from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 - Allergy and Infectious Diseases Research, supports a systems analysis of immune responses to norovirus infection in a human challenge model. The research aims to delineate the transcriptomic responses in human peripheral blood and stool samples collected from volunteers before and after controlled infection with different strains and doses of norovirus. The goal is to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,336,490 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Sloan-Kettering Institute for Cancer Research in New York, NY. The 5-year grant, awarded on August 6, 2024, supports research to understand B cell and antibody responses to placental versus foreign antigens, with the goal of illuminating how dysregulated responses contribute to pregnancy complications and informing...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is supporting research to investigate how human intestinal epithelial cells respond to and defend against rotavirus infection. The key products and services to be delivered include: Conducting research to unravel how rotavirus infection activates the STING pathway in intestinal epithelial cells, leading to the selective...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $793,102 to Wake Forest University Health Sciences (WFUHS) to investigate the interplay of maternal antibody and newborn vaccine responses to influenza virus. The goal is to effectively vaccinate young infants when maternal antibody levels are high, so that as maternal antibody wanes, a protective...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $729,006 to The Children's Hospital of Philadelphia Research Institute to conduct research on how adenovirus manipulates host RNA-binding proteins to exploit cellular RNA processing pathways and overcome host defenses. The 5-year project, running from January 2025 to December 2029, will employ innovative proteomics and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $593,021.00 to Washington University to conduct a mechanistic investigation of a rotavirus auxiliary protein, NSP6, and its role in countering host immune defenses. The 5-year project, starting on June 20, 2025 and ending on May 31, 2030, aims to define the key structural features of NSP6 that enable immune...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $242,310 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Trustees of Boston University's Medical Campus to establish a human intestinal organoid model for studying late-stage Ebola virus and Marburg virus infections. The project aims to characterize how these filovirus infections compromise the integrity of the intestinal epithelial barrier and disrupt ion flux, which can lead to...